These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15928308)

  • 1. Re: Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
    Popat S; Smith IE
    J Natl Cancer Inst; 2005 Jun; 97(11):858; author reply 858-9. PubMed ID: 15928308
    [No Abstract]   [Full Text] [Related]  

  • 2. Sometimes a great notion--an assessment of neoadjuvant systemic therapy for breast cancer.
    Davidson NE; Morrow M
    J Natl Cancer Inst; 2005 Feb; 97(3):159-61. PubMed ID: 15687353
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
    Mauri D; Pavlidis N; Ioannidis JP
    J Natl Cancer Inst; 2005 Feb; 97(3):188-94. PubMed ID: 15687361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for operable breast cancer.
    Mieog JS; van der Hage JA; van de Velde CJ
    Br J Surg; 2007 Oct; 94(10):1189-200. PubMed ID: 17701939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant chemotherapy and chemoradiotherapy of operable gastric cancer: an overview].
    Skoropad VIu; Berdov BA
    Vopr Onkol; 2004; 50(5):524-32. PubMed ID: 15715091
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.
    Newman LA; Mamounas EP
    Surg Clin North Am; 2007 Apr; 87(2):279-305, vii. PubMed ID: 17498527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for breast cancers: current recommendations and future directions.
    Andre F; Delaloge S
    Eur J Cancer; 2009 Sep; 45 Suppl 1():368-70. PubMed ID: 19775634
    [No Abstract]   [Full Text] [Related]  

  • 8. Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings.
    Mamounas EP
    Ann Surg Oncol; 2008 Mar; 15(3):691-703. PubMed ID: 18196346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy for breast cancer.
    Buzdar AU
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):212, 215. PubMed ID: 16163183
    [No Abstract]   [Full Text] [Related]  

  • 10. [Breast carcinoma. Preoperative chemotherapy can preserve the breast].
    MMW Fortschr Med; 2002 Oct; 144(42):63. PubMed ID: 12534003
    [No Abstract]   [Full Text] [Related]  

  • 11. Better treatment for breast cancer in older patients.
    Tran P; Fentiman IS
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1081-90. PubMed ID: 19671028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 4th large meta-analysis of all trials of the treatment of operable breast cancer: increased survival after a longer follow-up].
    van Nes JG; Nortier WR; van de Velde CJ
    Ned Tijdschr Geneeskd; 2005 Sep; 149(36):1978-80. PubMed ID: 16171107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.
    Oh JL; Dryden MJ; Woodward WA; Yu TK; Tereffe W; Strom EA; Perkins GH; Middleton L; Hunt KK; Giordano SH; Oswald MJ; Domain D; Buchholz TA
    J Clin Oncol; 2006 Nov; 24(31):4971-5. PubMed ID: 17075114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in breast conservation therapy.
    Newman LA; Kuerer HM
    J Clin Oncol; 2005 Mar; 23(8):1685-97. PubMed ID: 15755977
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in the hormonal treatment of breast cancer.
    Boughey JC; Buzdar AU; Hunt KK
    Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions.
    Mathew J; Asgeirsson KS; Cheung KL; Chan S; Dahda A; Robertson JF
    Eur J Surg Oncol; 2009 Feb; 35(2):113-22. PubMed ID: 18502088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of early breast cancer. IV: neoadjuvant treatment.
    Smith I; Chua S
    BMJ; 2006 Jan; 332(7535):223-4. PubMed ID: 16439402
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoadjuvant use of endocrine therapy in breast cancer.
    Macaskill EJ; Dixon JM
    Breast J; 2007; 13(3):243-50. PubMed ID: 17461898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
    Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
    J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: should we know more?
    Seruga B; Ocana A; Niraula S; Amir E
    J Clin Oncol; 2010 Jul; 28(20):e346-7; author reply e348. PubMed ID: 20458046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.